About the Author
Dr. Michael Fossel earned both his PhD and MD from Stanford
University, where he taught neurobiology and research methods.
Winner of a National Science Foundation fellowship, he was a
clinical professor of medicine for almost three decades, the
executive director of the American Aging Association, and the
founding editor of Rejuvenation Research. In 1996, he wrote
the first book on the telomerase theory of aging, Reversing
Human Aging, describing the medical aspects of extending human
telomeres, reversing aging, and curing age-related disease. In
2004, he authored the magisterial academic textbook, Cells,
Aging, and Human Disease, and in 2011, he coauthored The
Immortality Edge, a bestselling discussion of the potential for
extending the human lifespan. He currently teaches The Biology of
Aging at Grand Valley State University.
The world's foremost expert on the clinical use of telomerase for
age-related diseases, Michael has lectured at the National
Institute for Health and the Smithsonian Institute, and continues
to lecture at universities, institutes, and conferences throughout
the world. He has appeared on Good Morning America, ABC 20/20, NBC
Extra, Fox Network, CNN, BBC, Discovery Channel, and regularly on
NPR. He is currently working to bring telomerase to human trials
for Alzheimer's disease.
Reviews
"To those curious about telomerase therapy and its potentially
earth-shaking implications, this book is definitely worth a
read."
-Yale Scientific
"
The Telomerase Revolution is a remarkable book, telling a
fascinating story that pulls together at last a single coherent
theory of how and why growing old leads to so many different forms
of illness. It also offers a tantalizing promise that we might soon
know not only how to cure and prevent age-related diseases, but how
to reset the aging process itself. Michael Fossel is a radical
optimist."
Matt Ridley, author of Genome and The Rational
Optimist
"For a more optimistic glimpse of the future, try Michael Fossel's
fascinating account of how we might halt and reverse the process of
aging. Mr. Fossel argues that the mechanism behind all chronic
diseases of old age, even Alzheimer's, lies in the shortening of
chromosomal repeats called telomeres. Given that all cells are
equipped with a gene capable of preventing that shortening, and
some use it, why not try switching that gene on indie people's
bodies to halt aging? It may not be easy, but it's unlikely to be
impossible. Aging might be cured one day."
The Wall Street Journal
"Telomerase Therapy breaks down centuries of human thought on aging
and uproots outdated ideologies that have led to nothing but
worthless snake oil products. Dr. Fossel's exciting book is opening
doors to extended healthspan that can change human history, and
it's all grounded in solid scientific research."
Noel Patton, founder and chairman of TA Sciences
"Michael Fossel's compelling argument for the telomere approach to
reversing aging isn't just worth a look it's like reading the words
of Virgil as he leads us along the mysteries of aging."
Alexey Olovnikov, PhD, Institute of Biochemical Physics and
Russian Academy of Sciences
"Aging is not an irreversible degenerative process, but an
epigenetically determined physiological mechanism, which must not
be confused with age-related diseases caused by lifestyle choices.
Here, we have an effective and clear guide to understand how we get
old and how to tame aging in a few years."
Giacinto Libertini, MD, member of the Italian Society of
Evolutionary Biology
"As a follow-up to his previous publications on the subject, Dr.
Fossel brings the reader up-to-date on the progress made in
understanding the central role of the telomere in aging. . . .
Although a couple of decades of effort have ensued and candidate
interventions have emerged, there are no strong and clinically
proven interventions at the fore; however, Dr. Fossel constructs a
very optimistic but realistic view of what may be on horizon to
create the Telomerase Revolution."
Donald K. Ingram, PhD, professor at the Nutritional Neuroscience
and Aging Laboratory, Pennington Biomedical Research
Center
